Structure-activity relationship of bile acids and bile acid analogs in regard to FXR activation
Open Access
- 1 January 2004
- journal article
- Published by Elsevier in Journal of Lipid Research
- Vol. 45 (1) , 132-138
- https://doi.org/10.1194/jlr.m300215-jlr200
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- 6α-Ethyl-Chenodeoxycholic Acid (6-ECDCA), a Potent and Selective FXR Agonist Endowed with Anticholestatic ActivityJournal of Medicinal Chemistry, 2002
- Vitamin D Receptor As an Intestinal Bile Acid SensorScience, 2002
- Hypocholesterolemic Effect of Bile Acid Sulfonate Analogs in Hamsters.Biological & Pharmaceutical Bulletin, 2001
- Identification of the DNA Binding Specificity and Potential Target Genes for the Farnesoid X-activated ReceptorJournal of Biological Chemistry, 2000
- Catabolites of Cholesterol Synthesis Pathways and Forskolin as Activators of the Farnesoid X-Activated Nuclear ReceptorToxicology and Applied Pharmacology, 2000
- Bile acid sulfonate and 7-alkylated bile acid analogs: Effect on intestinal absorption of taurocholate and cholesterol 7α-hydroxylase activity in cultured rat hepatocytesSteroids, 2000
- Effects of different bile salts on steady-state mRNA levels and transcriptional activity of cholesterol 7α-hydroxylaseHepatology, 1994
- Effects of different bile salts on steady-state mRNA levels and transcriptional activity of cholesterol 7α-hydroxylaseHepatology, 1994
- Bile acid biosynthesisBiochemistry, 1992
- Synthesis of bile acid analogs: 7-alkylated chenodeoxycholic acidsSteroids, 1989